Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis (COMFORT)
COMFORT: Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis
This study is being done to better understand how the study team can treat pain for people with cirrhosis and depression.
Enrolled participants on this feasibility study will be randomized to Transcutaneous Electrical Acustimulation (TEA) or sham TEA.
研究概览
地位
条件
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Andrea MacMichael
- 电话号码:734-232-4182
- 邮箱:amacmi@umich.edu
学习地点
-
-
Michigan
-
Ann Arbor、Michigan、美国、48109
- University of Michigan
-
首席研究员:
- Elliot Tapper, MD
-
接触:
- Melanie Tapper
- 电话号码:734-232-4182
- 邮箱:etapper@umich.edu
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、美国、19104
- University of Pennsylvania
-
接触:
- Richard Mason, PharmD
- 电话号码:215-349-8986
- 邮箱:Richard.Mason@pennmedicine.upenn.edu
-
首席研究员:
- Marina Serper, MD, MS
-
接触:
- Jacqueline Theroux, MPH
- 电话号码:215-662-3904
- 邮箱:Jacqueline.Theroux@pennmedicine.upenn.edu
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Diagnosis of cirrhosis - must meet the criteria as outlined in the protocol
- Chronic pain (Patient self-reports ≥ 4 on the 0-10 scale for >50% of days within 3- months)
- Willing to use a Transcutaneous Electrical Acustimulation (TEA) device
- Has access to Wi-Fi or a data plan
- Has access to a laptop, computer, tablet, or smartphone
Exclusion Criteria:
- Dementia and/or severe cognitive impairment
- Unable or unwilling to provide consent
- Expected to undergo liver transplant in next 24 weeks
- No email address
- Deemed unsuitable by the study investigator
- Model for End-Stage Liver Diseas (MELD) score >25, or total bilirubin >4.0 in a patient on hemodialysis
- Recent hospitalization (>24 hours) or episode of hepatic encephalopathy within the preceding 30 days
- Implanted pacemaker/defibrillator, spinal implant, or cochlear implant
- Known allergy to adhesive tape/electrode materials
- Current active suicidal ideation, endorsed at screening (see Section 8.6)
- Currently pregnant (self-reported)
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:经牙(TEA)
参与者将有为期两周的跑步期,然后进行8周的治疗。
|
Participant will apply TEA at home twice a day (approximately 45 minutes am/pm) for 8 weeks. The top electrode will be placed at an acupuncture point and the electrode patch will be placed vertically. Additionally, participants will agree to allow medical records to be collected, complete various surveys and have follow-up after treatment. |
|
假比较器:茶假
参与者将有为期两周的跑步期,然后进行8周的假治疗。
|
Participant will apply sham TEA at home twice a day (approximately 45 minutes am/pm) for 8 weeks.
Sham TEA will be performed via one point on the leg and not on any meridian or acupoints that were used in previous gastrointestinal studies and did not yield any significant effects.
Additionally, participants will agree to allow medical records to be collected, complete various surveys and have follow-up after treatment
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Retention
大体时间:Approximately day -14, day 1, and day 56
|
Approximately day -14, day 1, and day 56
|
|
|
Device adherence
大体时间:Approximately week 8
|
Reported as percent, reported from device utilization logs
|
Approximately week 8
|
|
Questionnaire completion
大体时间:Approximately week 8
|
Reported as percent
|
Approximately week 8
|
|
Acceptability of Intervention Measure (AIM) score
大体时间:Approximately week 8 and week 12
|
AIM is a 6-item study-specific Likert battery with scores ranging from 0-5.
Higher scores indicate lower acceptability.
|
Approximately week 8 and week 12
|
合作者和调查者
调查人员
- 首席研究员:Elliot Tapper, MD、University of Michigan
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.